Bruush Oral Care Inc.
BRSH · NASDAQ
4/30/2023 | 12/31/2022 | 10/31/2022 | 7/31/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $1 | $1 | $1 |
| % Growth | -53.5% | -11.3% | 8% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $1 | $1 |
| % Margin | 75.6% | 58.3% | 66.2% | 77.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $1 | $1 | $2 | $1 |
| SG&A Expenses | $2 | $4 | $6 | $2 |
| Sales & Mktg Exp. | $1 | $2 | $4 | $0 |
| Other Operating Expenses | $0 | -$0 | $0 | $0 |
| Operating Expenses | $2 | $3 | $6 | $2 |
| Operating Income | -$1 | -$3 | -$6 | -$1 |
| % Margin | -439.6% | -466.8% | -740.6% | -153.5% |
| Other Income/Exp. Net | $1 | $0 | $5 | -$0 |
| Pre-Tax Income | -$0 | -$3 | -$1 | -$1 |
| Tax Expense | $0 | $0 | -$5 | -$0 |
| Net Income | -$0 | -$3 | $5 | -$1 |
| % Margin | -145.9% | -398.4% | 576.3% | -148.2% |
| EPS | -0.95 | -6.4 | 13.96 | -0.18 |
| % Growth | 85.2% | -145.8% | 7,855.6% | – |
| EPS Diluted | -0.95 | -6.4 | 13.96 | -0.18 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 6 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 6 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $1 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1 | -$3 | -$6 | -$1 |
| % Margin | -439.3% | -466.7% | -739.8% | -124.4% |